GM
33
-2
REGN
29
4
F
47
4
NI
62
6
DNB
52
4
VRSK
63
9
TROW
24
-7
IVZ
18
3
LYB
11
7
HIG
66
3
EIX
42
3
LLY
45
6
HON
52
5
DE
53
14
ADI
41
3
DUK
59
5
VFC
38
5
AMG
50
4
BF.B
50
4
MAS
56
2
GM
33
-2
REGN
29
4
F
47
4
NI
62
6
DNB
52
4
VRSK
63
9
TROW
24
-7
IVZ
18
3
LYB
11
7
HIG
66
3
EIX
42
3
LLY
45
6
HON
52
5
DE
53
14
ADI
41
3
DUK
59
5
VFC
38
5
AMG
50
4
BF.B
50
4
MAS
56
2
Financhill
Back

Pliant Therapeutics 10K Form

Sell
15

PLRX
Pliant Therapeutics

Last Price:
$1.34
Seasonality Move:
-12.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PLRX News And Ratings

See the #1 stock for the next 7 days that we like better than PLRX

PLRX Financial Statistics

Sales & Book Value

Annual Sales: $1.6M
Cash Flow: $-47.9M
Price / Cash Flow: 0
Annual Sales: $5.00
Price / Book: 0.27

Profitability

EPS (TTM): -3.47000
Net Income (TTM): $-210.3M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Pliant Therapeutics Earnings Forecast

Key Pliant Therapeutics Financial Ratios

  • Per Share Earnings over the last 7 years have been positive in 2 years.

Pliant Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: PLRX
CUSIP: 729139
Website: pliantrx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PLRX Technical Analysis vs Fundamental Analysis

Sell
15
Pliant Therapeutics (PLRX) is a Sell

Is Pliant Therapeutics a Buy or a Sell?